JUPITER NEUROSCIENCES, INC. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 27, 2026, Jupiter Neurosciences received notice of failure to satisfy continued listing standards. The 8-K filing indicates Item 3.01 delisting notice and Item 8.01 other events, but the filing text provided does not specify which exchange, which listing rule was violated, the cure period, or remediation details.
Why this rating
Delisting threatens public trading status and liquidity for $20.2M market-cap company; existential risk to shareholder value and access to capital markets.
Extracted items
- 3.01 delisting notice
- 8.01 other event
- 9.01 exhibits
Tradability signal
NO TRADE
No trade: only ~$64k traded in the last 30 min — too illiquid to enter and exit.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $4.40 ▲ 3.43% | at our read · backfill $4.25 | +10 min · backfill $4.08 ▼ 4.00% | +30 min · backfill $3.85 ▼ 9.41% | +1 hr · backfill $3.43 ▼ 19.29% |
The stock had already moved -3.32% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.